Selected research
Industry Growth & Trends
Global Chemical API CDMO Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Chemical API CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chemical API CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Chemical API CDMO market include Flamma Group, HAS Healthcare, Asymchem, Recipharm, Pierre Fabre, Pfizer CentreOne, Axplora, Lonza and MAI CDMO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chemical API CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chemical API CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chemical API CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chemical API CDMO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Chemical API CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chemical API CDMO Market by Company
Flamma Group
HAS Healthcare
Asymchem
Recipharm
Pierre Fabre
Pfizer CentreOne
Axplora
Lonza
MAI CDMO
BioVectra
Curia
AGC Pharma Chemicals
Asymchem
Olon Group
Evonik Health Care
Teva Active Pharmaceutical Ingredients
Chemical API CDMO Segment by Type
Small Molecule CDMO
Macromolecule CDMO
Cell Gene Therapy (CGT) CDMO
Chemical API CDMO Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Chemical API CDMO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemical API CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chemical API CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemical API CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Chemical API CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecule CDMO
- Macromolecule CDMO
- Cell Gene Therapy (CGT) CDMO
Applications
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Hospital
- Others
Companies covered
- Flamma Group
- HAS Healthcare
- Asymchem
- Recipharm
- Pierre Fabre
- Pfizer CentreOne
- Axplora
- Lonza
- MAI CDMO
- BioVectra
- Curia
- AGC Pharma Chemicals
- Asymchem
- Olon Group
- Evonik Health Care
- Teva Active Pharmaceutical Ingredients
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Chemical API CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Chemical API CDMO Market Size by Region (2021-2032)
- 1.4.1 Global Chemical API CDMO Market Size by Region (2021-2026)
- 1.4.2 Global Chemical API CDMO Market Size by Region (2027-2032)
- 1.5 Key Regions Chemical API CDMO Market Size (2021-2032)
- 1.5.1 North America Chemical API CDMO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Chemical API CDMO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Chemical API CDMO Market Size Growth Rate (2021-2032)
- 1.5.4 South America Chemical API CDMO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Chemical API CDMO Market Size Growth Rate (2021-2032)
2 Chemical API CDMO Market by Type
- 2.1 Type Introduction
- 2.1.1 Small Molecule CDMO
- 2.1.2 Macromolecule CDMO
- 2.1.3 Cell Gene Therapy (CGT) CDMO
- 2.2 Global Chemical API CDMO Market Size by Type
- 2.2.1 Global Chemical API CDMO Market Size Overview by Type (2021-2032)
- 2.2.2 Global Chemical API CDMO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Chemical API CDMO Market Size Forecasted by Type (2027-2032)
- 2.3 Global Chemical API CDMO Market Size by Regions
- 2.3.1 North America Chemical API CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Chemical API CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Chemical API CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Chemical API CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Chemical API CDMO Market Size Breakdown by Type (2021-2026)
3 Chemical API CDMO Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical and Biotechnology Companies
- 3.1.2 Research and Academic Institutions
- 3.1.3 Hospital
- 3.1.4 Others
- 3.2 Global Chemical API CDMO Market Size by Application
- 3.2.1 Global Chemical API CDMO Market Size Overview by Application (2021-2032)
- 3.2.2 Global Chemical API CDMO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Chemical API CDMO Market Size Forecasted by Application (2027-2032)
- 3.3 Global Chemical API CDMO Market Size by Regions
- 3.3.1 North America Chemical API CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Chemical API CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Chemical API CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Chemical API CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Chemical API CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Chemical API CDMO Industry Trends
- 4.2 Chemical API CDMO Industry Drivers
- 4.3 Chemical API CDMO Industry Opportunities and Challenges
- 4.4 Chemical API CDMO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Chemical API CDMO Revenue (2021-2026)
- 5.2 Global Chemical API CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Chemical API CDMO Key Company Headquarters & Area Served
- 5.4 Global Chemical API CDMO Company, Product Type & Application
- 5.5 Global Chemical API CDMO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Chemical API CDMO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Chemical API CDMO Players Market Share by Revenue in 2025
- 5.6.3 2025 Chemical API CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Flamma Group
- 6.1.1 Flamma Group Company Information
- 6.1.2 Flamma Group Business Overview
- 6.1.3 Flamma Group Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Flamma Group Chemical API CDMO Product Portfolio
- 6.1.5 Flamma Group Recent Developments
- 6.2 HAS Healthcare
- 6.2.1 HAS Healthcare Company Information
- 6.2.2 HAS Healthcare Business Overview
- 6.2.3 HAS Healthcare Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 HAS Healthcare Chemical API CDMO Product Portfolio
- 6.2.5 HAS Healthcare Recent Developments
- 6.3 Asymchem
- 6.3.1 Asymchem Company Information
- 6.3.2 Asymchem Business Overview
- 6.3.3 Asymchem Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Asymchem Chemical API CDMO Product Portfolio
- 6.3.5 Asymchem Recent Developments
- 6.4 Recipharm
- 6.4.1 Recipharm Company Information
- 6.4.2 Recipharm Business Overview
- 6.4.3 Recipharm Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Recipharm Chemical API CDMO Product Portfolio
- 6.4.5 Recipharm Recent Developments
- 6.5 Pierre Fabre
- 6.5.1 Pierre Fabre Company Information
- 6.5.2 Pierre Fabre Business Overview
- 6.5.3 Pierre Fabre Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pierre Fabre Chemical API CDMO Product Portfolio
- 6.5.5 Pierre Fabre Recent Developments
- 6.6 Pfizer CentreOne
- 6.6.1 Pfizer CentreOne Company Information
- 6.6.2 Pfizer CentreOne Business Overview
- 6.6.3 Pfizer CentreOne Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Pfizer CentreOne Chemical API CDMO Product Portfolio
- 6.6.5 Pfizer CentreOne Recent Developments
- 6.7 Axplora
- 6.7.1 Axplora Company Information
- 6.7.2 Axplora Business Overview
- 6.7.3 Axplora Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Axplora Chemical API CDMO Product Portfolio
- 6.7.5 Axplora Recent Developments
- 6.8 Lonza
- 6.8.1 Lonza Company Information
- 6.8.2 Lonza Business Overview
- 6.8.3 Lonza Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Lonza Chemical API CDMO Product Portfolio
- 6.8.5 Lonza Recent Developments
- 6.9 MAI CDMO
- 6.9.1 MAI CDMO Company Information
- 6.9.2 MAI CDMO Business Overview
- 6.9.3 MAI CDMO Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 MAI CDMO Chemical API CDMO Product Portfolio
- 6.9.5 MAI CDMO Recent Developments
- 6.10 BioVectra
- 6.10.1 BioVectra Company Information
- 6.10.2 BioVectra Business Overview
- 6.10.3 BioVectra Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 BioVectra Chemical API CDMO Product Portfolio
- 6.10.5 BioVectra Recent Developments
- 6.11 Curia
- 6.11.1 Curia Company Information
- 6.11.2 Curia Business Overview
- 6.11.3 Curia Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Curia Chemical API CDMO Product Portfolio
- 6.11.5 Curia Recent Developments
- 6.12 AGC Pharma Chemicals
- 6.12.1 AGC Pharma Chemicals Company Information
- 6.12.2 AGC Pharma Chemicals Business Overview
- 6.12.3 AGC Pharma Chemicals Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 AGC Pharma Chemicals Chemical API CDMO Product Portfolio
- 6.12.5 AGC Pharma Chemicals Recent Developments
- 6.13 Asymchem
- 6.13.1 Asymchem Company Information
- 6.13.2 Asymchem Business Overview
- 6.13.3 Asymchem Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Asymchem Chemical API CDMO Product Portfolio
- 6.13.5 Asymchem Recent Developments
- 6.14 Olon Group
- 6.14.1 Olon Group Company Information
- 6.14.2 Olon Group Business Overview
- 6.14.3 Olon Group Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Olon Group Chemical API CDMO Product Portfolio
- 6.14.5 Olon Group Recent Developments
- 6.15 Evonik Health Care
- 6.15.1 Evonik Health Care Company Information
- 6.15.2 Evonik Health Care Business Overview
- 6.15.3 Evonik Health Care Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Evonik Health Care Chemical API CDMO Product Portfolio
- 6.15.5 Evonik Health Care Recent Developments
- 6.16 Teva Active Pharmaceutical Ingredients
- 6.16.1 Teva Active Pharmaceutical Ingredients Company Information
- 6.16.2 Teva Active Pharmaceutical Ingredients Business Overview
- 6.16.3 Teva Active Pharmaceutical Ingredients Chemical API CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Teva Active Pharmaceutical Ingredients Chemical API CDMO Product Portfolio
- 6.16.5 Teva Active Pharmaceutical Ingredients Recent Developments
7 North America
- 7.1 North America Chemical API CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Chemical API CDMO Market Size by Country (2021-2026)
- 7.3 North America Chemical API CDMO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Chemical API CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Chemical API CDMO Market Size by Country (2021-2026)
- 8.3 Europe Chemical API CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Chemical API CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Chemical API CDMO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Chemical API CDMO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Chemical API CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Chemical API CDMO Market Size by Country (2021-2026)
- 10.3 South America Chemical API CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Chemical API CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Chemical API CDMO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Chemical API CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst